No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Particle size, magnetic field, and blood velocity effects on particle retention in magnetic drug targeting
2.M. Johannsen, U. Gneveckow, L. Eckelt, A. Feussner, N. Waldofner, R. Scholz, S. Deger, P. Wust, S. A. Loening, and A. Jordan, “Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique,” Int. J. Hyperthermia 21, 637–647 (2005).
3.C. Alexiou, R. Jurgons, C. Seliger, O. Brunke, H. Iro, and S. Odenbach, “Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting,” Anticancer Res. 27, 2019–2022 (2007).
4.R. Jurgons, C. Seliger, A. Hilpert, L. Trahms, S. Odenbach, and C. Alexiou, “Drug loaded magnetic nanoparticles for cancer therapy,” J. Phys.: Condens. Matter 18, S2893–S2902 (2006).
5.C. H. Cunningham, T. Arai, P. C. Yang, M. V. McConnell, J. M. Pauly, and S. M. Conolly, “Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles,” Magn. Reson. Med. 53, 999–1005 (2005).
6.A. Ito, K. Ino, M. Hayashida, T. Kobayashi, H. Matsunuma, H. Kagami, M. Ueda, and H. Honda, “Novel methodology for fabrication of tissue-engineered tubular constructs using magnetite nanoparticles and magnetic force,” Tissue Eng. 11, 1553–1561 (2005).
7.A. Ito, Y. Takizawa, H. Honda, K. I. Hata, H. Kagami, M. Ueda, and T. Kobayashi, “Tissue engineering using magnetite nanoparticles and magnetic force: Heterotypic layers of cocultured hepatocytes and endothelial cells,” Tissue Eng. 10, 833–840 (2004).
8.C. Alexiou, W. Arnold, R. J. Klein, F. G. Parak, P. Hulin, C. Bergemann, W. Erhardt, S. Wagenpfeil, and A. S. Lubbe, “Locoregional cancer treatment with magnetic drug targeting,” Cancer Res. 60, 6641–6648 (2000).
10.A. M. Derfus, G. von Maltzahn, T. J. Harris, T. Duza, K. S. Vecchio, E. Ruoslahti, and S. N. Bhatia, “Remotely triggered release from magnetic nanoparticles,” Adv. Mater. 19, 3932–3936 (2007).
11.S. H. Hu, T. Y. Liu, D. M. Liu, and S. Y. Chen, “Controlled pulsatile drug release from a ferrogel by a high-frequency magnetic field,” Macromolecules 40, 6786–6788 (2007).
12.D. H. Kim, D. E. Nikles, D. T. Johnson, and C. S. Brazel, “Heat generation of aqueously dispersed CoFe2O4 nanoparticles as heating agents for magnetically activated drug delivery and hyperthermia,” J. Magn. Magn. Mater. 320, 2390–2396 (2008).
13.C. Alexiou, R. Jurgons, R. J. Schmid, C. Bergemann, J. Henke, W. Erhardt, E. Huenges, and F. Parak, “Magnetic drug targeting: Biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment,” J. Drug Target. 11, 139–149 (2003).
14.C. Alexiou, A. Schmidt, R. Klein, P. Hulin, C. Bergemann, and W. Arnold, “Magnetic drug targeting: Biodistribution and dependency on magnetic field strength,” J. Magn. Magn. Mater. 252, 363–366 (2002).
15.A. Senyei, K. Widder, and G. Czerlinski, “Magnetic guidance of drug-carrying microspheres,” J. Appl. Phys. 49, 3578–3583 (1978).
16.C. Alexiou, R. Jurgons, R. Schmid, A. Hilpert, C. Bergemann, F. Parak, and H. Iro, “In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles,” J. Magn. Magn. Mater. 293, 389–393 (2005).
17.A. S. Lübbe et al., “Clinical experiences with magnetic drag targeting: A phase I study with -epidoxorubicin in 14 patients with advanced solid tumors,” Cancer Res. 56, 4686–4693 (1996).
19.J. B. Mathieu and S. Martel, “Magnetic microparticle steering within the constraints of an MRI system: Proof of concept of a novel targeting approach,” Biomed. Microdevices 9, 801–808 (2007).
20.C. Alexiou, D. Diehl, P. Henninger, H. Iro, R. Rockelein, W. Schmidt, and H. Weber, “A high field gradient magnet for magnetic drug targeting,” IEEE Trans. Appl. Supercond. 16, 1527–1530 (2006).
21.C. G. Caro, The Mechanics of the Circulation (Oxford University Press, Oxford, New York, 1978).
22.C. T. Crowe, M. Sommerfeld, and Y. Tsuji, Multiphase Flows with Droplets and Particles (CRC, Boca Raton, 1998).
24.M. O. Aviles, A. D. Ebner, and J. A. Ritter, “In vitro study of magnetic particle seeding for implant assisted-magnetic drug targeting,” J. Magn. Magn. Mater. 320, 2640–2646 (2008).
25.P. J. Cregg, K. Murphy, and A. Madinoglu, “Inclusion of magnetic dipole-dipole and hydrodynamic interactions in implant-assisted magnetic drug targeting,” J. Magn. Magn. Mater. 321, 3893–3898 (2009).
26.C. Mikkelsen, M. F. Hansen, and H. Bruns, “Theoretical comparison of magnetic and hydrodynamic interactions between magnetically tagged particles in microfluidic systems,” J. Magn. Magn. Mater. 293, 578–583 (2005).
27.P. B. L. Kar, W. Yung, and D. D. Villani, “An analytic solution for the force between two magnetic dipoles,” Magn. Electr. Sep. 9, 39–52 (1998).
28.M. Babincová, P. Babinec, and C. Bergemann, “High-gradient magnetic capture of ferrofluids: Implications for drug targeting and tumor embolization,” Z. Naturforsch [C] 56, 909–911 (2001).
29.M. Babincová, V. Altanerova, M. Lampert, C. Altaner, E. Machova, M. Sramka, and P. Babinec, “Site-specific in vivo targeting of magnetoliposomes using externally applied magnetic field,” Z. Naturforsch [C] 55, 278–281 (2000).
31.J. Kreuter, “Evaluation of nanoparticles as drug-delivery systems.1. Preparation methods,” Pharm. Acta Helv. 58, 196–209 (1983).
32.S. M. Moghimi, A. C. Hunter, and J. C. Murray, “Long-circulating and target-specific nanoparticles: Theory to practice,” Pharmacol. Rev. 53, 283–318 (2001).
Article metrics loading...
Full text loading...
Most read this month